NK

Nazeer Khan Shamsudeen

Active Director Director DIN 11057358
DIN 11057358 First appointment Apr 2025 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value •••• Premium profile

About Nazeer Khan Shamsudeen

Data last updated:

Nazeer Khan Shamsudeen is a Director at Cleomed Biotech Limited (since 2025). The company operates in Trading. Cleomed Biotech Limited reported revenue of ₹1.56 Cr (FY 2025).

DIN 11057358
Primary Designation Director
Industry Trading
First Appointment 16 Apr 2025
Oldest Company Age 4 yrs
Largest company Cleomed Biotech Limited · ₹1.56 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cleomed Biotech Limited U17299KL2022PLC074338
Director16 Apr 20252022₹1.56 Cr (FY 2025)Active

Board colleagues of Nazeer Khan Shamsudeen

Directorship timeline

Open interactive timeline →
Cleomed Biotech Limited
Premium access

Shareholding and investment profile for Nazeer Khan Shamsudeen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nazeer Khan Shamsudeen

Nazeer Khan Shamsudeen currently holds 1 directorship: Cleomed Biotech Limited (Director, since 16 Apr 2025, revenue ₹1.56 Cr (FY 2025)).

Nazeer Khan Shamsudeen was first appointed on 16 Apr 2025 as Director at Cleomed Biotech Limited.

The current boards of Nazeer Khan Shamsudeen's companies include Aswathy Nair Madhusudhanan (Cleomed Biotech Limited), Hari Karookonath Sukumarapillai (Cleomed Biotech Limited), Sujith Kodangattu Velathuvalappil (Cleomed Biotech Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available